Stock analysis for PharmaCyte Biotech Inc (PMCB:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. The share repurchase program does not obligate PharmaCyte to acquire a specific dollar amount or number of shares and may be extended, modified, or discontinued. PMCB - PharmaCyte Biotech, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). PharmaCyte Biotech is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell. The current price of PMCB is USD — it has increased by % in the past 24 hours. Watch PharmaCyte Biotech, Inc. stock price performance more closely on.
PharmaCyte Biotech stock quote and PMCB charts. Latest stock price today and the US' most active stock market forums. Monitor the latest movements within the PharmaCyte Biotech Inc real time stock price chart below. What Is the PharmaCyte Biotech Inc Stock Price Today? The. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Find the latest PharmaCyte Biotech Inc. (PMCB) stock quote, history, news and other vital information to help you with your stock trading and investing. A high-level overview of PharmaCyte Biotech, Inc. (PMCB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. The reverse stock split will reduce the number of shares of the Company's outstanding common stock from approximately billion shares to approximately PharmaCyte Biotech Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Get the latest PharmaCyte Biotech Inc. (PMCB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Explore the latest news, in-depth analysis, performance evaluation, and Q&A for PharmaCyte Biotech, Inc. (PMCB) stock. Gain valuable insights from earnings. PharmaCyte Biotech Inc. · AT CLOSE PM EDT 09/05/24 · USD · % · Volume33, As of August 02, , Pharmacyte Biotech Inc had a $ million market capitalization, putting it in the 18th percentile of companies in the Pharmaceuticals.
Detailed Stock Quote · Stock Charts · Historical Quotes. This Week. Exchange. NCM. Market Data copyright © QuoteMedia. Data delayed 15 minutes. PharmaCyte Biotech's stock loses more than half its value ahead of Nasdaq debut. The shares of PharmaCyte Biotech Inc. plummeted % in premarket trading. Discover historical prices for PMCB stock on Yahoo Finance. View daily, weekly or monthly format back to when PharmaCyte Biotech, Inc. stock was issued. PharmaCyte Biotech, Inc NASDAQ: PMCB is a biotechnology company focused on PMCB Stock Price. PMCB Drug Pipeline. Drug. Stage. Status. Next Catalyst. Historical Data · Detailed Stock Quote · Stock Charts · Historical Quotes. Track PharmaCyte Biotech Inc (PMCB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range. See the latest PharmaCyte Biotech Inc stock price (PMCB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Discover real-time PharmaCyte Biotech, Inc. Common Stock (PMCB) stock prices, quotes, historical data, news, and Insights for informed trading and.
PMCB - PharmaCyte Biotech Inc - Stock screener for investors and traders, financial visualizations. Stock Information ; Symbol. Nasdaq:PMCB ; Price. $ ; Change. What is the current stock price of PharmaCyte Biotech (PMCB)?. The current stock price of PharmaCyte Biotech (PMCB) is $ as of September 4, (NASDAQ: PMCB) Pharmacyte Biotech stock price per share is $ today (as of Aug 23, ). PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease. LAS VEGAS--(BUSINESS WIRE)
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and. Get PharmaCyte Biotech, Inc. (PMCB) real-time share value, investment, rating and financial market information from Capital. Friendly Platforms & Trading. PharmaCyte Biotech (PMCB) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. The biotech company PharmaCyte Biotech Inc trades as PMCB stock on the Nasdaq All Markets. PharmaCyte Biotech, Inc. is a biotechnology company.